Advisor Resource Council’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-65,388
Closed -$1.55M 461
2025
Q1
$1.55M Buy
+65,388
New +$1.71M 0.13% 184
2024
Q4
Sell
-7,901
Closed -$229K 214
2024
Q3
$229K Buy
+7,901
New +$230K 0.1% 206
2024
Q2
Sell
-10,011
Closed -$288K 173
2024
Q1
$288K Sell
10,011
-10,557
-51% -$293K 0.12% 172
2023
Q4
$592K Buy
20,568
+12,075
+142% +$365K 0.07% 251
2023
Q3
$282K Sell
8,493
-1,460
-15% -$51.6K 0.15% 114
2023
Q2
$365K Sell
9,953
-3,888
-28% -$151K 0.16% 100
2023
Q1
$578K Buy
13,841
+3,321
+32% +$143K 0.15% 161
2022
Q4
$539K Buy
10,520
+77
+0.7% +$3.69K 0.26% 75
2022
Q3
$457K Sell
10,443
-23,628
-69% -$1.15M 0.31% 86
2022
Q2
$1.79M Buy
34,071
+947
+3% +$48.3K 0.17% 139
2022
Q1
$1.72M Sell
33,124
-23,917
-42% -$1.24M 0.52% 54
2021
Q4
$3.37M Buy
57,041
+22,572
+65% +$1.12M 0.26% 80
2021
Q3
$1.48M Sell
34,469
-13,407
-28% -$594K 0.45% 62
2021
Q2
$1.87M Buy
+47,876
New +$1.86M 0.2% 116

Other funds holding PFE

Advisor Resource Council's PFE Position: Q2 2025 in Review

Advisor Resource Council sold out of Pfizer (PFE) in Q2 2025, closing a stake of 65,388 shares — an estimated $1.55M sold.

Advisor Resource Council first reported a position in PFE in Q2 2021 and held it in 14 quarters. The position peaked at $3.37M in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Advisor Resource Council reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Advisor Resource Council sold 65,388 Pfizer shares in Q2 2025, an estimated $1.55M.
  • Advisor Resource Council first reported a position in Pfizer in Q2 2021 and held it in 14 quarters.
  • Advisor Resource Council's Pfizer position peaked at $3.37M in Q4 2021.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Advisor Resource Council's 13F filing for Q2 2025, filed 11 Aug 2025.